New approaches to neuroscience create Bright Minds

Pipeline

Our Approach

Healing the central nervous system & brain through the regulation of serotonin

Based on a proprietary chemistry platform Bright Minds have developed highly selective 5-HT2A and 5-HT2C agonists without 5-HT2B activity.

Our Science

Our team of neuroscientists, drug developers and physicians are tackling the big problems in mental health and neurology

Our Team

The A team in brain health innovation

Ian McDonald

Chief Executive Officer, Director

Jan Torleif Pedersen

Director, Chief Science Officer

Stephen D. Collins

Chief Medical Officer

Alex Vasilkevich

Chief Operating Officer, Senior Scientific Officer

Ryan Cheung

Chief Financial Officer

Dr. John McCorvy Ph.D

Senior Advisor